Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app improve healthcare for new parents and babies?

NCT ID NCT05595486

Knowledge-focused Sponsor: Women and Infants Hospital of Rhode Island Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a mobile app called Baby2Home designed to help new families get the healthcare they need after childbirth. Over 600 parents and their babies took part, with some using the app and others getting usual care. The goal was to see if the app improved checkups, vaccines, and mental health screening for both parents and infants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Baby2Home mobile health application
What this could lead to
If successful, this app could help new parents and babies get better preventive care, like checkups and vaccines, and reduce gaps in care for different groups.
What could go wrong
This is a completed trial, but the app may not work for everyone, especially those without smartphones or English skills. Results may not apply to all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

642 people

The number who actually took part.

Started

Nov 2022

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Delivery at Prentice Women's Hospital or Women and Infants Hospital of Rhode Island * Viable term infant (≥ 37 weeks) * First live born child * English speaking * Age 18 years old or greater * Access to a smartphone * Access to a working email address Exclusion Criteria: * No smartphone access * Infant death * Infant requires NICU admission * Known severe mental illness of either parent (e.g., bipolar disorder, schizophrenia) * SARS-CoV-2 infection without clinical clearance * History of IPV (intimate partner violence) with current partner (would exclude partner) * Concurrent enrollment in studies that may affect the outcome of the trial (or vice versa)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 pandemic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior COVID-19 perinatal asphyxia postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 pandemic Health knowledge, attitudes, practice Mental health wellness Perinatal depression Post partum depression

Contacts and locations

Locations

  • Northwestern Medicine Prentice Women's Hospital

    Chicago, Illinois, 60611, United States

  • Women and Infant's Hospital

    Providence, Rhode Island, 02905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.